Prasun Bhattacharya
Overview
Explore the profile of Prasun Bhattacharya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
293
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pandey S, Maity C, Samanta S, Talukdar A, Das A, Paul S, et al.
Indian J Pathol Microbiol
. 2024 Apr;
67(3):596-601.
PMID: 38563700
Introduction And Aims: The direct antiglobulin test (DAT) is an important diagnostic tool for immune hemolytic anemia (IHA). The present study was primarily aimed to identify the prevalence of DAT...
2.
Raychaudhuri D, Bandopadhyay P, DRozario R, Sarif J, Ray Y, Paul S, et al.
Mayo Clin Proc Innov Qual Outcomes
. 2022 Sep;
6(6):511-524.
PMID: 36117954
Objective: To assess the clinical and immunological benefits of passive immunization using convalescent plasma therapy (CPT). Materials And Methods: A series of subclass analyses were performed on the previously published...
3.
Park H, Tarpey T, Liu M, Goldfeld K, Wu Y, Wu D, et al.
JAMA Netw Open
. 2022 Jan;
5(1):e2147375.
PMID: 35076698
Importance: Identifying which patients with COVID-19 are likely to benefit from COVID-19 convalescent plasma (CCP) treatment may have a large public health impact. Objective: To develop an index for predicting...
4.
Ray Y, Paul S, Bandopadhyay P, DRozario R, Sarif J, Raychaudhuri D, et al.
Nat Commun
. 2022 Jan;
13(1):383.
PMID: 35046397
A single center open label phase 2 randomised control trial (Clinical Trial Registry of India No. CTRI/2020/05/025209) was done to assess clinical and immunological benefits of passive immunization using convalescent...
5.
Sarif J, Raychaudhuri D, DRozario R, Bandopadhyay P, Singh P, Mehta P, et al.
Front Immunol
. 2021 Nov;
12:738093.
PMID: 34777349
Disease caused by SARS-CoV-2 coronavirus (COVID-19) led to significant morbidity and mortality worldwide. A systemic hyper-inflammation characterizes severe COVID-19 disease, often associated with acute respiratory distress syndrome (ARDS). Blood biomarkers...
6.
Bandopadhyay P, DRozario R, Lahiri A, Sarif J, Ray Y, Paul S, et al.
J Infect Dis
. 2021 Aug;
224(4):565-574.
PMID: 34398242
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causing coronavirus disease 2019 (COVID-19), has led to significant morbidity and mortality. While most suffer from mild symptoms, some patients progress to...
7.
Biswas D, Maiti C, Talukder B, Azharuddin M, Saha S, Pandey S, et al.
ISBT Sci Ser
. 2021 Jul;
16(4):276-283.
PMID: 34226835
Background And Objectives: The COVID-19 pandemic has spread across 87 million people with more than 1·8 million deaths in the world. As there is no definite treatment modality, the use...
8.
Naik A, Bhattacharya P, Das P, Mukherjee K, Mukhopadhyay P
Asian J Transfus Sci
. 2021 Mar;
14(2):119-125.
PMID: 33767537
Objectives: Detection of maternal irregular antibodies against red blood cell antigen is vital in the management of hemolytic disease of fetus and newborn. There are no uniform guidelines related to...
9.
Naik A, Bhattacharya P, Datta S
Indian J Hematol Blood Transfus
. 2020 May;
36(2):403-405.
PMID: 32425399
No abstract available.
10.
Basu D, Datta S, Montemayor C, Bhattacharya P, Mukherjee K, Flegel W
Transfus Med Hemother
. 2018 Mar;
45(1):62-66.
PMID: 29593462
Background: Few studies have documented the blood group antigens in the population of eastern India. Frequencies of some common alleles and haplotypes were unknown. We describe phenotype, allele, and haplotype...